Optiscan live with FIVE 1
Thursday, 12 June, 2008
Australian confocal microscopy specialist Optiscan Imaging (ASX: OIL) is expanding the global market for its endomicroscopes, including setting up a US sales office to further awareness of its FIVE 1 endomicroscope for pre-clinical research.
FIVE 1, or fluorescence in vivo endomicroscopy, is aimed at cellular research, including stem cell and tissue regeneration research.
Optiscan also has a partnership with Pentax to develop flexible endomicroscopes, which are being used in a global clinical trial.
Optiscan has set up a sales office in San Diego, California, and has distributors throughout Europe and Asia.
Lead exposure linked to memory problems, even decades later
Historic lead levels from the era of leaded petrol may be contributing to cognitive issues 50...
New vulnerability found in the aging brain
An international research team has discovered that in the aging brain, certain proteins are lost...
Genetic weak spot found in hard-to-treat cancers
Research shows that blocking minor splicing can markedly slow tumour growth in liver, lung and...
